Vysis 06N38-010
Ref 06N38-010
Vysis 06N38-010 is an in vitro diagnostic device (EU IVDR Class C; FDA Class II; EMDN category tests for acquired genetic or chromosomal alterations) made by Abbott Molecular, registered in EUDAMED on 4 Nov 2026 (Basic UDI-DI 0884999CDN0638UY) and listed in FDA GUDID since 20 Nov 2014 (UDI-DI 00884999025738), active as of 7 Nov 2026.
Active
CE IVDR
Valid until
No date given
FDA recalls
Not checked
Documents
None linked in EUDAMED
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number0884999CDN0638UY 00884999025738 | Date4 Nov 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00884999025738 | Date20 Nov 2014 | StatusListed |
Official records
- EUDAMED public site 0884999CDN0638UY
- AccessGUDID record 00884999025738
From the FDA record
- Device description
- ProbeChek ALK Positive Control Slides
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI 0884999CDN0638UY registered 4 Nov 2026 Active
- FDA GUDID UDI-DI 00884999025738 listed 20 Nov 2014 Listed
Timeline
- Listed FDA GUDID 00884999025738
- Registered EUDAMED 0884999CDN0638UY
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Vysis
- Generic name
- Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
- Device name
- Vysis ALK Break Apart FISH Probe Kit
- Model / Ref / Catalog
- 06N38-010
- Primary DI / UDI-DI
- 00884999025738
- Basic UDI-DI
- 0884999CDN0638UY
- FDA product code
- OYU, OWE
- EMDN code
- W01060299 Tests for acquired genetic or chromosomal alterations - other
- GMDN term
- Anaplastic lymphoma kinase (ALK) genetic mutation IVD, control
- Device class
- Class C EUDAMEDClass II GUDID
- Regulation number
- 866.4700, 864.1890
- EU registration type
- Standard device
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class C | Class II |
Similar devices in this category
Other devices filed under TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER.
- LeukoStrat CDx FLT3 Mutation Assay K4120431 by Invivoscribe, Inc.
- Oncomine™ Dx Target RNA Control Kit A32443 (A49756) by LIFE TECHNOLOGIES LIMITED
- Fast Fluorescence In Situ Hybridization Probe Kit FP-006 by Wuhan HealthCare Biotechnology Co., Ltd.
- GynTect GT003-10 by Epitype GmbH
- Del(7q) Deletion Probe CE-LPH 025-S by Cytocell, Ltd.
- Diagnostic Kit for Methylated Genes of Breast Cancer(Real Time PCR) BRC-PCR-30-CE by Excellen Medical Technology Co., Ltd.
- OncoMate MSI Dx Analysis System by Promega Corporation
- AmoyDx® NRAS Mutation Detection Kit 8.01.0172 by Amoy Diagnostics Co., LTD.
- TRUPCR® BCR-ABL1 Kit - Quantitative Major (WHO IS) 3B1252 by 3B BlackBio Dx Limited
- DNA Methylation Detection Kit for Human PAX1, SOX1 and HAS1 Gene (Real-Time PCR) 213301 by Yaneng BIOscience (Shenzhen) Co., Ltd.